MCT1 was observed in several cancers, such as breast and colorectal cancers30, 31, while MCT2 and MCT4 were highly expressed in prostate cancer and renal cell carcinoma, respectively32, 33. This evidence concerns the gene SLC16A7 and prostate cancer.